logo
This health care stock forming a 'big base breakout' is ready to separate from the pack, charts indicate

This health care stock forming a 'big base breakout' is ready to separate from the pack, charts indicate

CNBC24-07-2025
While the health care sector has been a chronic underperformer in recent years, our process is showing that a number of stocks in this struggling sector are exhibiting real signs of strength. With an encouraging earnings report this week, followed by an impressive breakout above resistance, Boston Scientific Corp. (BSX) may be setting up for significant gains beyond current levels. The daily chart shows how BSX is setting up with a classic "big base breakout" pattern, where a multi-month consolidation pattern is finally exited with a significant upside move. As legendary technical analyst Alan Shaw used to say, "The bigger the base, the higher in space!" So after six months of sideways price action, including a test of the 200-day moving average at the April low, BSX appears to be completing a bullish rotation above resistance around $106.50. In terms of upside price targets after a breakout of this magnitude, a common technique is to take the height of the consolidation pattern and project that range to the upside. Given the range of around $20 for this pattern, that would imply a minimum upside objective around $126, representing about a 17% gain from current levels. To further validate this breakout scenario, we can analyze volume indicators to determine whether there is enough buying power represented in the charts. Here we're showing Boston Scientific along with three volume indicators. First, we have the raw daily volume readings, shown just below the daily price bars. Then we are showing the Accumulation/Distribution Line, which represents the trend in volume over time. Finally, we've included the Chaikin Money Flow, which uses daily price and volume movements to measure periods of accumulation and distribution. We can see that Wednesday's rally after the earnings release was marked by about double the normal volume. This shows that significant demand was seen for Boston Scientific as investors literally bought into the bullish case for future earnings growth. The Accumulation/Distribution Line has been trending higher for most of the last 12 months, and the Chaikin Money Flow remains firmly above the zero level. These two technical indicators suggest that BSX is in a period of accumulation, suggesting a bullish outlook with further upside potential. The weekly chart shows that the consolidation from the last six months has indeed represented a brief pause within a multiyear rally phase for Boston Scientific. Since a key breakout above resistance in early 2023, BSX has remained in a consistent uptrend phase with improving relative strength. Two major pullbacks during the uptrend phase, in October 2023 and March 2025, saw this health care name find support at an ascending 40-week moving average. So while BSX has underperformed the S & P 500 in recent months, the long-term trend remains on solid footing. Many investors have been ignoring the health sector in 2025, given the chronic underperformance and questionable technical configurations. But charts like BSX provide an important reminder that even the most chart-challenged sectors can often include stocks that stand out with bullish setups. -David Keller, CMT marketmisbehavior.com DISCLOSURES: (None) All opinions expressed by the CNBC Pro contributors are solely their opinions and do not reflect the opinions of CNBC, NBC UNIVERSAL, their parent company or affiliates, and may have been previously disseminated by them on television, radio, internet or another medium. THE ABOVE CONTENT IS SUBJECT TO OUR TERMS AND CONDITIONS AND PRIVACY POLICY . THIS CONTENT IS PROVIDED FOR INFORMATIONAL PURPOSES ONLY AND DOES NOT CONSITUTE FINANCIAL, INVESTMENT, TAX OR LEGAL ADVICE OR A RECOMMENDATION TO BUY ANY SECURITY OR OTHER FINANCIAL ASSET. THE CONTENT IS GENERAL IN NATURE AND DOES NOT REFLECT ANY INDIVIDUAL'S UNIQUE PERSONAL CIRCUMSTANCES. THE ABOVE CONTENT MIGHT NOT BE SUITABLE FOR YOUR PARTICULAR CIRCUMSTANCES. BEFORE MAKING ANY FINANCIAL DECISIONS, YOU SHOULD STRONGLY CONSIDER SEEKING ADVICE FROM YOUR OWN FINANCIAL OR INVESTMENT ADVISOR. Click here for the full disclaimer.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Why AI Robotics Stock Symbotic Surged 38.9% in July
Why AI Robotics Stock Symbotic Surged 38.9% in July

Yahoo

time20 minutes ago

  • Yahoo

Why AI Robotics Stock Symbotic Surged 38.9% in July

Key Points More analysts are turning bullish on Symbotic after its Walmart deal. The stock has more than doubled in just six months. Symbotic shares could cool off a bit from here, but there's nothing to worry about. 10 stocks we like better than Symbotic › Symbotic (NASDAQ: SYM) stock has gone ballistic. A stunning rally of 38.9% in July drove the stock's half-yearly performance to a staggering 127.5%, according to data provided by S&P Global Market Intelligence. On Aug. 5, Symbotic hit a 52-week high of $64.16 per share. Symbotic automates warehouses and distribution centers with its artificial intelligence (AI)-powered robots and software. Symbotic's deal with Walmart (NYSE: WMT), in particular, has spurred massive investor interest in its stock, with several analysts upgrading their price targets in recent weeks. Why are analysts turning bullish on Symbotic stock? Analysts from Citi, Arete, Northland, and Oppenheimer were among those that initiated coverage or upgraded their price targets on Symbotic stock in July. While Arete has a price target of $50 per share on Symbotic, analysts from Northland raised their price target on the AI stock to $56 per share from $35 a share. Citi analyst Andrew Kaplowitz upped the stock's price target to $60 from $29 per share. Oppenheimer analyst Colin Rusch, meanwhile, raised Symbotic's price target from $35 per share to $54 a share in July, and then by another $5 in early August. In January, Symbotic acquired Walmart's advanced systems and robotics (ASR) business and signed a commercial agreement with the retail giant to deploy robotics automation systems for up to 400 accelerated pickup and delivery (APD) centers at Walmart stores over the next few years. Symbotic estimates incremental backlog of $5 billion from the deal. As news of Walmart testing "dark stores" to fulfill online orders hit the headlines in late June and through July, investors analysts bumped up their expectations from Symbotic stock and drove its price higher. Shares hit a new 52-week high of $64.16 ahead of earnings on Aug. 5. Could Symbotic stock lose momentum from here? Symbotic beat estimates with 26% year-over-year growth in revenue for its third quarter. Its net loss, however, widened to $32 million from $21 million a year ago because of restructuring charges. Moreover, the company's Q4 revenue guidance of $590 million to $610 million would mean only 4% year-over-year growth at the midpoint. Investors don't want to see a deceleration in sales from a growth stock that's yet to turn profitable. Yet investors should also look beyond the headlines. Symbotic is ready to deploy a next-generation storage system at warehouses that should significantly improve storage capacity and handling. The company, however, is facing startup problems, but expects them to be a temporary blip. Management insisted that none of it affects the company's backlog, which stands at a solid $22.4 billion today. To put that number into perspective, Symbotic generated revenue worth $1.8 billion last year. Long story short, Symbotic could face some quarters of slow revenue growth, but that shouldn't hurt the long-term growth potential of this AI and robotics stock. Should you invest $1,000 in Symbotic right now? Before you buy stock in Symbotic, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the for investors to buy now… and Symbotic wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $649,544!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $1,113,059!* Now, it's worth noting Stock Advisor's total average return is 1,062% — a market-crushing outperformance compared to 185% for the S&P 500. Don't miss out on the latest top 10 list, available when you join Stock Advisor. See the 10 stocks » *Stock Advisor returns as of August 13, 2025 Citigroup is an advertising partner of Motley Fool Money. Neha Chamaria has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Symbotic and Walmart. The Motley Fool has a disclosure policy. Why AI Robotics Stock Symbotic Surged 38.9% in July was originally published by The Motley Fool Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Main Street investors are running the show this year, not Wall Street
Main Street investors are running the show this year, not Wall Street

CNBC

time22 minutes ago

  • CNBC

Main Street investors are running the show this year, not Wall Street

Institutional investors are once again playing catch up with retail traders, according to JPMorgan. Mom and pop, retail investors have bought newly crowned meme stocks like OpenDoor for months, according to the Wall Street investment bank. But only recently have big investors also jumped into this trade. The bet has paid off: After seven straight losing months, OpenDoor posted a dizzying rally of 245% in July, and is up another 30% so far in August. OPEN 3M mountain OpenDoor shares over the past 3 months This marks only the latest example of small investors leading the charge this year, according to Arun Jain, a global markets strategist at the bank. "As an interesting pattern within 'Meme' stocks ... retail buying in prior months is followed by non-retails joining the trade more recently," Jain wrote to clients in a Wednesday note. "This is in line with our reading on the broader market." Jain also pointed to retail investors "buying the dip" following President Donald Trump's initial wave of higher tariffs in April. Those investors benefited when stocks rallied after Trump later said he would delay many of those charges. The S & P 500 has jumped almost 19% since the closing low on April 8, less than a week after the original tariff announcement on April 2 . .SPX 6M mountain The S & P 500, 6 months Big investors aimed to regain ground via higher-beta plays, Jain said. As a result, he found high-beta crowding to be at an all-time high and thinks this corner of the market could be due for a pullback. Right now, retail traders are showing a preference for exchange-traded funds such as the SPDR S & P 500 ETF Trust (SPY) and SPDR S & P 500 ETF Trust (QQQ) over single stocks, according to JPMorgan data. But not all ETFs are getting the same treatment. Jain said the iShares Semiconductor ETF (SOXX) and the Direxion Daily Semiconductor Bull 3X Shares (SOXL) ETF were both among the most sold on a net basis over the past week.

Compared to Estimates, Nice (NICE) Q2 Earnings: A Look at Key Metrics
Compared to Estimates, Nice (NICE) Q2 Earnings: A Look at Key Metrics

Yahoo

timean hour ago

  • Yahoo

Compared to Estimates, Nice (NICE) Q2 Earnings: A Look at Key Metrics

For the quarter ended June 2025, Nice (NICE) reported revenue of $726.71 million, up 9.4% over the same period last year. EPS came in at $3.01, compared to $2.64 in the year-ago quarter. The reported revenue represents a surprise of +1.79% over the Zacks Consensus Estimate of $713.92 million. With the consensus EPS estimate being $2.99, the EPS surprise was +0.67%. While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance. As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately. Here is how Nice performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts: Revenue by Business Model- Cloud: $540.82 million versus the seven-analyst average estimate of $539.96 million. The reported number represents a year-over-year change of +12.3%. Revenue by Business Model- Services: $140.48 million versus $142.15 million estimated by seven analysts on average. Compared to the year-ago quarter, this number represents a -4.8% change. Revenue by Business Model- Product: $45.41 million versus the seven-analyst average estimate of $31.8 million. The reported number represents a year-over-year change of +29.4%. View all Key Company Metrics for Nice here>>> Shares of Nice have returned -2.5% over the past month versus the Zacks S&P 500 composite's +3.5% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Nice (NICE) : Free Stock Analysis Report This article originally published on Zacks Investment Research ( Zacks Investment Research Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store